Functional arginine vasopressin system in early heart maturation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 4, 2007, Pages

  Gutkowska, Jolanta ^a   Miszkurka, Malgorzata ^a   Danalache, Bogdan ^a   Gassanov, Natig ^a,b   Wang, Donghao ^a   Jankowski, Marek ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cardiomyocyte differentiation; Heart maturation; Immunochemistry; Vasopressin; Vasopressin receptors

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN[1 DEAMINO]; CYCLIC AMP; GREEN FLUORESCENT PROTEIN; MYOSIN LIGHT CHAIN; NEUROHYPOPHYSIS HORMONE; TRANSCRIPTION FACTOR GATA 4; TROPONIN C;

ADOLESCENT; ADVENTITIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HEART DEVELOPMENT; HEART MUSCLE CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 35349009038     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01320.2006     Document Type: Article

References (48)

1. Almazan G, Lefebvre DL, Zingg HH. Ontogeny of hypothalamic vasopressin, oxytocin and somatostatin gene expression. Dev Brain Res 45: 69-75, 1989.
2. Anderson PA. Maturation and cardiac contractility. Cardiol Clin 7: 209-251, 1989.
3. Antunes-Rodrigues J, de Castro M, Elias LL, Valenca MM, McCann SM. Neuroendocrine control of body fluid metabolism. Physiol Rev 84: 169-208, 2004.
4. Balment RJ, Brimble MJ, Forsling ML, Musabayane CT. Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range. J Physiol 352: 517-526, 1984.
5. Bankir L, Fernandes S, Bardoux P, Bouby N, Bichet DG. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 16: 1920-1928, 2005.
6. Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 318: 881-887, 1988.
7. Chen Y, Shao JZ, Xiang LX, Guo J, Zhou QJ, Yao X, Dai LC, Lu YL. Cyclic adenosine 3′,5′-monophosphate induces differentiation of mouse embryonic stem cells into cardiomyocytes. Cell Biol Int 30: 301-307, 2006.
8. 3 receptors but has no effect in mature cortical neurons. J Neurosci Res 60: 761-766, 2000.
9. Danalache BA, Paquin J, Wang D, Grygorczyk R, Moore JC, Mummery CL, Gutkowska J, Jankowski M. Nitric oxide signalling in oxytocin-mediated cardiomyogenesis. Stem Cells 25: 679-688, 2007.
10. 1 receptor. Mol Cell Biochem 195: 93-98, 1999.
11. Gassanov N, Jankowski M, Danalache B, Wang D, Grygorczyk R, Hoppe UC, Gutkowska J. Arginine vasopressin-mediated cardiac differentiation: insights into the role of its receptors and nitric oxide signaling. J Biol Chem 282: 11255-11265, 2007.
12. Goldsmith SR, Francis GS, Cowley AW Jr, Levine TB, Cohn JN. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol 1: 1385-1390, 1983.
13. Gutkowska J. Radioimmunoassay for atrial natriuretic factor. Nucl Med Biol 14: 323-331, 1987.
14. Hartman RD, Rosella-Dampman LM, Emmert SE, Summy-Long JY. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation. Endocrinology 119: 1-11, 1986.
15. Hatami L, Valojerdi MR, Mowla SJ. Effects of oxytocin on cardiomyocyte differentiation from mouse embryonic stem cells. Int J Cardiol 17: 80-89, 2007.
16. 2 receptor mRNA in rats. Eur J Pharmacol 267: 71-75, 1994.
17. Holmes CL, Landry DW, Granton JT. Vasopressin and the cardiovascular system. 1. Receptor physiology. Crit Care 7: 427-434, 2003.
18. Horackova M, Croll RP, Hopkins DA, Losier AM, Armour JA. Morphological and immunohistochemical properties of primary long-term cultures of adult guinea-pig ventricular cardiomyocytes with peripheral cardiac neurons. Tissue Cell 28: 411-425, 1996.
19. Hunter T. Signaling - 2000, beyond. Cell 100: 113-127, 2000.
20. Hupf H, Grimm D, Riegger GA, Schunkert H. Evidence for a vasopressin system in the rat heart. Circ Res 84: 365-370, 1999.
21. Jankowski M, Danalache B, Wang D, Bhat P, Hajjar F, Marcinkiewicz M, Paquin J, McCann SM, Gutkowska J. Oxytocin in cardiac ontogeny. Proc Natl Acad Sci USA 101: 13074-13079, 2004.
22. 2 receptor- and cAMP-mediated signaling. J Thromb Haemost 1: 821-828, 2003.
23. 2 vasopressin receptor improves contractile force of rat cardiomyocytes. Circulation 99: 925-933, 1999.
24. Lee CR, Watkins ML, Patterson JH, Gattis W, O'Connor CM, Gheorghiade M, Adams KF Jr. Vasopressin: a new target for the treatment of heart failure. Am Heart J 146: 9-18, 2003.
25. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, Sano M, Toko H, Akazawa H, Sato T, Nakaya H, Kasanuki H, Komuro I. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279: 11384-11391, 2004.
26. Moore JC, Spijker R, Martens AC, de Boer T, Rook MB, van der Heyden MA, Tertoolen LG, Mummery CL. A P19Cl6 GFP reporter line to quantify cardiomyocyte differentiation of stem cells. Int J Dev Biol 48: 47-55, 2004.
27. Muders F, Elsner D, Schunkert H, Riegger GA, Palkovits M. Central vasopressin in experimental aortic stenosis in the rat. Am J Hypertens 12: 311-314, 1999.
28. 1A receptor. Eur J Pharmacol 391: 39-48, 2000.
29. Page E, Winterfield J, Goings G, Bastawrous A, Upshaw-Earley J. Water channel proteins in rat cardiac myocyte caveolae: osmolarity-dependent reversible internalization. Am J Physiol Heart Circ Physiol 274: H1988-H2000, 1998.
30. Paquin J, Danalache BA, Jankowski M, McCann SM, Gutkowska J. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA 99: 9550-9555, 2002.
31. Parmley WW. Neuroendocrine changes in heart failure and their clinical relevance. Clin Cardiol 18: 440-445, 1995.
32. Patil RV, Han Z, Wax MB. Regulation of water channel activity of aquaporin 1 by arginine vasopressin and atrial natriuretic peptide. Biochem Biophys Res Commun 238: 392-396, 1997.
33. Pruszczynski W, Vahanian A, Ardaillou R, Acar J. Role of antidiuretic hormone in impaired water excretion of patients with congestive heart failure. J Clin Endocrinol Metab 58: 599-605, 1984.
34. Rouleau JL, Packer M, Moye L, De Champlain J, Bichet D, Klein M, Rouleau JR, Sussex B, Arnold JM, Sestier F, et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 24: 583-591, 1994.
35. 2+/calmodulin-dependent kinase and calcineurin pathways. Mol Biol Cell 16: 3632-3641, 2005.
36. Sinding C, Seif SM, Robinson AG. Levels of neurophyseal peptides in the rat during the first month of life. Endocrinology 107: 749-754, 1980.
37. Takayanagi Y, Yoshids M, Bielsky IF, Ross HE, Kawamata M, Onaka T, Yanagisawa T, Kimura T, Matzuk MM, Young LJ, Nishimori K. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci USA 102: 16096-16101, 2005.
38. Teti A, Naro F, Molinaro M, Adamo S. Transduction of arginine vasopressin signal in skeletal myogenic cells. Am J Physiol Cell Physiol 265: C113-C121, 1993.
39. Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC. Human vascular endothelial cells express oxytocin receptors. Endocrinology 140: 1301-1309, 1999.
40. Uchida S, Fuke Tsukahara T. Upregulations of GATA4 and oxytocin receptor are important in cardiomyocyte differentiation processes of P19CL6 cells. J Cell Biochem 100: 629-641, 2007.
41. Ugrumov MV. Magnocellular vasopressin system in ontogenesis: development and regulation. Microsc Res Tech 56: 164-171, 2002.
42. Van der Heyden MA, Defize LH. Twenty-one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc Res 58: 292-302, 2003.
43. Walker BR, Haynes J Jr, Wang HL, Voelkel NF. Vasopressin-induced pulmonary vasodilation in rats. Am J Physiol Heart Circ Physiol 257: H415-H422, 1989.
44. Wang D, Gutkowska J, Marcinkiewicz M, Rachelska G, Jankowski M. Genistein supplementation stimulates the oxytocin system in the aorta of ovariectomized rats. Cardiovasc Res 57: 186-194, 2003.
45. 2 vasopressin receptors in vivo by ultrasound-guided injection or transcoronary delivery. Circulation 101: 1578-1585, 2000.
46. 1 subtype receptors. Circ Res 69: 239-245, 1991.
47. Zaccolo M, Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295: 1711-1715, 2002.
48. Zingg HH, Laporte SA. The oxytocin receptor. Trends Endocrinol Metab 14: 222-227, 2003.